Search research articles
Contact Us
Filters
Showing results (121-130 of 264) with videos related to
Page
of 27
Sort By:
Pulmonary Circulation
|
December 7, 2020
Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies
Thenappan Thenappan, Nadine Al-Naamani, Stefano Ghio, et al.
Vascular Pharmacology
|
July 4, 2024
Sodium nitroprusside infusion in patients with advanced heart failure
Stefano Ghio, Egidio Traversi, Roberto Maestri, et al.
Vascular Pharmacology
|
July 19, 2023
Sacubitril/valsartan effects on arrhythmias and left ventricular remodelling in heart failure: An observational study
Mauro Acquaro, Laura Scelsi, Beatrice Pasotti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
September 16, 2014
Women with nonischemic cardiomyopathy have a favorable prognosis and a better left ventricular remodeling than men after cardiac resynchronization therapy
Manlio Cipriani, Maurizio Landolina, Fabrizio Oliva, et al.
European Journal of Heart Failure
|
October 19, 2010
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial
Stefano Ghio, Laura Scelsi, Roberto Latini, et al.
Circulation. Heart Failure
|
September 10, 2013
Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure
Cecilia Linde, Claude Daubert, William T Abraham, et al.
International Journal of Cardiology
|
November 28, 2012
Severe aortic valve stenosis with normal left ventricular function and low vs. high pressure gradient: different hemodynamic profiles but similar clinical presentation, comorbidity and outcome
Andrea Rossi, Stefano Nistri, Giovanni Cioffi, et al.
International Journal of Cardiology
|
January 8, 2013
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension
Guido Carlomagno, Giancarlo Messalli, Rosa Marina Melillo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
December 8, 2017
Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension: cLinical and haemodYnamic long-term efficacy (ITALY study)
Michele D'Alto, Emanuele Romeo, Paola Argiento, et al.
European Heart Journal
|
May 29, 2009
Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy
Sergio Leonardi, Claudia Raineri, Gaetano M De Ferrari, et al.
Page
of 27
Search research articles
Search
Showing results (121-130 of 264) with videos related to
Sort By:
Page
of 27
Pulmonary Circulation
|
December 7, 2020
Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies
Thenappan Thenappan, Nadine Al-Naamani, Stefano Ghio, et al.
Vascular Pharmacology
|
July 4, 2024
Sodium nitroprusside infusion in patients with advanced heart failure
Stefano Ghio, Egidio Traversi, Roberto Maestri, et al.
Vascular Pharmacology
|
July 19, 2023
Sacubitril/valsartan effects on arrhythmias and left ventricular remodelling in heart failure: An observational study
Mauro Acquaro, Laura Scelsi, Beatrice Pasotti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
September 16, 2014
Women with nonischemic cardiomyopathy have a favorable prognosis and a better left ventricular remodeling than men after cardiac resynchronization therapy
Manlio Cipriani, Maurizio Landolina, Fabrizio Oliva, et al.
European Journal of Heart Failure
|
October 19, 2010
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial
Stefano Ghio, Laura Scelsi, Roberto Latini, et al.
Circulation. Heart Failure
|
September 10, 2013
Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure
Cecilia Linde, Claude Daubert, William T Abraham, et al.
International Journal of Cardiology
|
November 28, 2012
Severe aortic valve stenosis with normal left ventricular function and low vs. high pressure gradient: different hemodynamic profiles but similar clinical presentation, comorbidity and outcome
Andrea Rossi, Stefano Nistri, Giovanni Cioffi, et al.
International Journal of Cardiology
|
January 8, 2013
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension
Guido Carlomagno, Giancarlo Messalli, Rosa Marina Melillo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
December 8, 2017
Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension: cLinical and haemodYnamic long-term efficacy (ITALY study)
Michele D'Alto, Emanuele Romeo, Paola Argiento, et al.
European Heart Journal
|
May 29, 2009
Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy
Sergio Leonardi, Claudia Raineri, Gaetano M De Ferrari, et al.
Page
of 27